- Home
- HCM vs RXRX Comparison
HCM vs RXRX Comparison
Compare HCM & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- RXRX
- Stock Information
- Founded
- HCM 2000
- RXRX 2013
- Country
- HCM Hong Kong
- RXRX United States
- Employees
- HCM N/A
- RXRX N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- HCM Health Care
- RXRX Health Care
- Exchange
- HCM Nasdaq
- RXRX Nasdaq
- Market Cap
- HCM 2.5B
- RXRX 2.4B
- IPO Year
- HCM N/A
- RXRX 2021
- Fundamental
- Price
- HCM $15.92
- RXRX $5.63
- Analyst Decision
- HCM Strong Buy
- RXRX Buy
- Analyst Count
- HCM 1
- RXRX 5
- Target Price
- HCM $28.00
- RXRX $7.00
- AVG Volume (30 Days)
- HCM 44.4K
- RXRX 27.5M
- Earning Date
- HCM 08-07-2025
- RXRX 08-05-2025
- Dividend Yield
- HCM N/A
- RXRX N/A
- EPS Growth
- HCM N/A
- RXRX N/A
- EPS
- HCM 0.53
- RXRX N/A
- Revenue
- HCM $602,197,000.00
- RXRX $64,596,000.00
- Revenue This Year
- HCM $15.00
- RXRX $19.96
- Revenue Next Year
- HCM $19.91
- RXRX $61.39
- P/E Ratio
- HCM $5.55
- RXRX N/A
- Revenue Growth
- HCM N/A
- RXRX 30.14
- 52 Week Low
- HCM $11.51
- RXRX $3.79
- 52 Week High
- HCM $21.50
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- HCM 43.91
- RXRX 49.91
- Support Level
- HCM $14.64
- RXRX $5.20
- Resistance Level
- HCM $16.17
- RXRX $5.82
- Average True Range (ATR)
- HCM 0.50
- RXRX 0.33
- MACD
- HCM -0.31
- RXRX -0.06
- Stochastic Oscillator
- HCM 24.90
- RXRX 27.27
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.